Mounting evidence has suggested that obesity-associated inflammation, so-called meta-inflammation, triggers glucose intolerance and type 2 diabetes by interrupting insulin signaling in insulin-target tissues [3, 4]. This evidence concerns the gene INS and type 2 diabetes mellitus.